Strictly for laboratory research use only
In the CY 2024 OPPS/ASC final rule with comment period and the CY 2024 PFS final rule, we codified this inflation-adjusted coinsurance amount at 419.41(e), 410.152(m), and 489.30(b)(6), respectively

use reconstituted solution within 7 days Dosing Protocol A structured dosing approach based on clinical use: Week 1: 1 mg (1000 mcg) daily (titration phase) Weeks 2+: 2 mg (2000 mcg) daily (standard dosage) Frequency: Once daily (subcutaneous) Timing: Preferably evening administration Cycle Length: Standard: 1226 weeks Extended: Up to 52 weeks with monitoring Site Rotation: Rotate injection areas regularly Storage Instructions Proper storage is essential to maintain stability and effectiveness: Lyophilized (unmixed): Store at 20C for long-term preservation Reconstituted: Keep refrigerated at 28C Shelf Life: Approximately 30 days after mixing Avoid repeated freezethaw cycles Allow vial to reach room temperature before opening to reduce moisture buildup Important Notes Use a new sterile insulin syringe (2730G) for each injection Dispose of all sharps safely after use Rotate injection sites to minimize irritation or tissue buildup Inject slowly and wait briefly before removing the needle Common temporary effects may include nausea, flushing, or mild headache Keeping a simple log of dose and injection site can help maintain consistency How This Works Tesamorelin mimics natural GHRH and binds to receptors in the pituitary gland, triggering the release of growth hormone

In my experience, the intramuscular route is superior to subcutaneous injections
Contact PlexusDx or your compounding pharmacy immediately
Likewise, its use is not recommended in patients with conditions requiring the restriction of vitamin B12 intake or those with a history of severe allergic reactions to B-complex vitamins